He is the Head of Serialization & Digital Enabling, Manufacturing Systems, Global Engineering at Takeda Pharmaceuticals, and Owns UPI (Unique Product Identifier process and system) and DA (Digital Authentication) process end to end to ensure compliance and patient protection, He Drives business value beyond pure compliance to leverage technology implemented Drives new technology to support DA and UPI/Track and Trace initiatives and Ensures new technology is embedded in our standard equipment in collaboration with head technology. Mr. Michael also monitors and improves OEE related to UPI/DA to ensure supply to patient. Previously he was the Cross Divisional Program Leader, Serialization & Tamper Evident at Novartis, and he was the Leader of a global USD$258M program spanning across 37 sites and 250 CMOs worldwide. He was also responsible for the design and definition of standardized templates coving Serialization & Product Tracking and Tamper Evident Packaging processes across the entire Novartis domain.